Eli Lilly & Co. has announced plans to manufacture its new weight-loss pill in the United States, supplying patients globally. This decision aligns with President Donald Trump’s push for companies to reshore production to American soil. In an interview with Fox Business Network, CEO Dave Ricks stated, “We’re going to make this medicine here in the United States. We’ll be proud to make this medicine at that site and ship it around the world from our country.”
— new from Bloomberg.com
